MCID: KLN001
MIFTS: 46

Klinefelter's Syndrome malady

Categories: Genetic diseases, Rare diseases

Aliases & Classifications for Klinefelter's Syndrome

About this section

Aliases & Descriptions for Klinefelter's Syndrome:

Name: Klinefelter's Syndrome 10 45 23 12 35
Klinefelter Syndrome 10 68 45 23 36 65
Xxy Trisomy 10 68 45 23 65
Xxy Syndrome 10 68 45 23
Hypogonadotropic Hypogonadism 10 22 65
 
Klinefelters Syndrome 47
47, Xxy 45
47 Xxy 45
47,xxy 68

Classifications:



External Ids:

Disease Ontology10 DOID:1921
ICD1027 Q98.0, Q98.4
ICD9CM29 758.7
MeSH36 D007713
NCIt42 C34752
UMLS65 C0022735, C0271623, C2930823

Summaries for Klinefelter's Syndrome

About this section
NIH Rare Diseases:45 47, xxy refers to the presence of an additional x chromosome in a person's body cells. some individuals with a 47, xxy chromosome finding do not appear different from other individuals, and they may have mild symptoms or no apparent symptoms. during the first few years of life, most 47, xxy males do not show any obvious differences from typical male infants and young boys. children may have slightly weaker muscles, delayed development of motor skills, and learning and/or language problems. in later adolescence and adulthood, 47, xxy males can have features of klinefelter syndrome, which can include primary hypogonadism (decreased testosterone production), small testes, enlarged breast tissue (gynecomastia), tall stature, and/or other features. although the vast majority of individuals with 47, xxy identify as males, some develop atypical gender identities. there have been reports of individuals with 47, xxy having a female physical appearance, but in most cases this was attributed to changes in specific genes related to sexual development. most 47, xxy males are infertile, but many produce sperm and may be able to conceive with assisted reproduction. treatment varies among individuals and may include testosterone therapy; however, this therapy may not be appropriate for all individuals. last updated: 9/20/2013

MalaCards based summary: Klinefelter's Syndrome, also known as klinefelter syndrome, is related to retroperitoneal sarcoma and leiomyoma, and has symptoms including decreased fertility, disproportionate tall stature and neurological speech impairment. An important gene associated with Klinefelter's Syndrome is DAZ4 (Deleted In Azoospermia 4), and among its related pathways are SIDS Susceptibility Pathways and Nongenotropic Androgen signaling. Affiliated tissues include breast, testes and bone, and related mouse phenotypes are adipose tissue and normal.

MedlinePlus:35 Klinefelter syndrome (ks) is a condition that occurs in men who have an extra x chromosome. the syndrome can affect different stages of physical, language, and social development. the most common symptom is infertility. boys may be taller than other boys their age, with more fat around the belly. after puberty, ks boys may have smaller testes and penis breast growth less facial and body hair reduced muscle tone narrower shoulders and wider hips weaker bones decreased sexual interest lower energy ks males may have learning or language problems. they may be quiet and shy and have trouble fitting in. a genetic test can diagnose ks. there is no cure, but treatments are available. it is important to start treatment as early as possible. with treatment, most boys grow up to have normal lives. treatments include testosterone replacement therapy and breast reduction surgery. if needed, physical, speech, language, and occupational therapy may also help. nih: national institute of child health and human development

Genetics Home Reference:23 Klinefelter syndrome is a chromosomal condition that affects male physical and cognitive development. Its signs and symptoms vary among affected individuals.

Wikipedia:68 Klinefelter syndrome or Klinefelter\'s syndrome (KS) (/ˈklaɪnfɛltər/) also known as 47,XXY or XXY,... more...

Related Diseases for Klinefelter's Syndrome

About this section

Diseases related to Klinefelter's Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 367)
idRelated DiseaseScoreTop Affiliating Genes
1retroperitoneal sarcoma30.9AR, CYP19A1
2leiomyoma30.6AR, CYP19A1, PRL
3pituitary adenoma30.2GNRH1, PRL
4hypogonadotropic hypogonadism 7 without anosmia12.7
5cerebellar ataxia and hypogonadotropic hypogonadism12.7
6hypogonadotropic hypogonadism 13 with or without anosmia12.7
7hypogonadotropic hypogonadism 15 with or without anosmia12.7
8hypogonadotropic hypogonadism 11 with or without anosmia12.7
9hypogonadotropic hypogonadism 16 with or without anosmia12.7
10hypogonadotropic hypogonadism 12 with or without anosmia12.7
11hypogonadotropic hypogonadism 9 with or without anosmia12.7
12hypogonadotropic hypogonadism 10 with or without anosmia12.7
13hypogonadotropic hypogonadism 8 with or without anosmia12.7
14leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism12.7
15leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism12.7
16hypogonadotropic hypogonadism 1 with or without anosmia12.7
17hypogonadotropic hypogonadism 4 with or without anosmia12.7
18hypogonadotropic hypogonadism 18 with or without anosmia12.7
19hypogonadotropic hypogonadism with or without anosmia12.7
20hypogonadotropic hypogonadism 20 with or without anosmia12.7
21hypogonadotropic hypogonadism 6 with or without anosmia12.7
22hypogonadotropic hypogonadism 14 with or without anosmia12.7
23hypogonadotropic hypogonadism 3 with or without anosmia12.7
24hypogonadotropic hypogonadism 5 with or without anosmia12.7
25hypogonadotropic hypogonadism 2 with or without anosmia12.6
26hypogonadotropic hypogonadism 17 with or without anosmia12.6
27hypogonadotropic hypogonadism 19 with or without anosmia12.6
28hypogonadotropic hypogonadism 21 with anosmia12.6
29hypogonadotropic hypogonadism 23 with or without anosmia12.6
30hypogonadotropic hypogonadism 24 without anosmia12.6
31adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism12.6
32hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism syndrome12.4
33normosmic congenital hypogonadotropic hypogonadism12.4
34hypogonadotropic hypogonadism without anosmia, x-linked12.4
35hypogonadotropic hypogonadism-frontoparietal alopecia syndrome12.4
36hypogonadotropic hypogonadism-retinitis pigmentosa syndrome12.4
37hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome12.4
38moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome12.4
39kallmann syndrome12.1
40boucher-neuhauser syndrome11.9
41pol iii-related leukodystrophies11.8
42isolated gonadotropin-releasing hormone deficiency11.7
4348,xxyy syndrome11.7
44hs6st1-related isolated gonadotropin-releasing hormone deficiency11.5
45kiss1-related isolated gonadotropin-releasing hormone deficiency11.5
46nsmf-related isolated gonadotropin-releasing hormone deficiency11.5
47prok2-related isolated gonadotropin-releasing hormone deficiency11.5
48sema3a-related isolated gonadotropin-releasing hormone deficiency11.5
49tac3-related isolated gonadotropin-releasing hormone deficiency11.5
50wdr11-related isolated gonadotropin-releasing hormone deficiency11.5

Graphical network of the top 20 diseases related to Klinefelter's Syndrome:



Diseases related to klinefelter's syndrome

Symptoms for Klinefelter's Syndrome

About this section

HPO human phenotypes related to Klinefelter's Syndrome:

(show all 21)
id Description Frequency HPO Source Accession
1 decreased fertility hallmark (90%) HP:0000144
2 disproportionate tall stature hallmark (90%) HP:0001519
3 neurological speech impairment hallmark (90%) HP:0002167
4 abnormality of chromosome segregation hallmark (90%) HP:0002916
5 cryptorchidism typical (50%) HP:0000028
6 long face typical (50%) HP:0000276
7 mandibular prognathia typical (50%) HP:0000303
8 single transverse palmar crease typical (50%) HP:0000954
9 obesity typical (50%) HP:0001513
10 scoliosis typical (50%) HP:0002650
11 eunuchoid habitus typical (50%) HP:0003782
12 clinodactyly of the 5th finger typical (50%) HP:0004209
13 reduced bone mineral density typical (50%) HP:0004349
14 venous insufficiency typical (50%) HP:0005293
15 hypoplasia of penis typical (50%) HP:0008736
16 abnormal hair quantity typical (50%) HP:0011362
17 abnormality of movement typical (50%) HP:0100022
18 abnormality of the mitral valve occasional (7.5%) HP:0001633
19 abnormality of calvarial morphology occasional (7.5%) HP:0002648
20 neoplasm occasional (7.5%) HP:0002664
21 type ii diabetes mellitus occasional (7.5%) HP:0005978

Drugs & Therapeutics for Klinefelter's Syndrome

About this section

Drugs for Klinefelter's Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MethyltestosteroneapprovedPhase 4, Phase 2, Phase 347458-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
17beta-Hydroxy-17-methylandrost-4-en-3-one
 
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methitest
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Testred C-III
Virilon
2
Testosteroneapproved, investigationalPhase 4, Phase 2, Phase 347458-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
Aveed
Axiron
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depo-testosterone
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Fortesta
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
Intrinsa
 
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Natesto nasal gel
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Gel
Testosterone Heptanoate
Testosterone Hydrate
Testosterone Propionate
Testosterone Undecanoate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
Vogelxo
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
3
Testosterone enanthatePhase 4, Phase 2, Phase 3474315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
4Testosterone undecanoatePhase 4, Phase 2, Phase 3474
5Anabolic AgentsPhase 4, Phase 2, Phase 3375
6Testosterone 17 beta-cypionatePhase 4, Phase 2, Phase 3474
7Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 2, Phase 39988
8Hormone AntagonistsPhase 4, Phase 2, Phase 310002
9Antineoplastic Agents, HormonalPhase 4, Phase 2, Phase 34256
10AndrogensPhase 4, Phase 2, Phase 31162
11HormonesPhase 4, Phase 2, Phase 3, Phase 111748
12Gastrointestinal AgentsPhase 2, Phase 36401
13CatharticsPhase 2, Phase 3344
14Castor OilPhase 2, Phase 320
15LaxativesPhase 2, Phase 3344
16CastorNutraceuticalPhase 2, Phase 321
17
IsotretinoinapprovedPhase 21154759-48-25538, 5282379
Synonyms:
(13-cis)-Retinoate
(13-cis)-Retinoic acid
(13cis)-retinoic acid
(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
(2Z,4E6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
(7E,9E,11E,13Z)-retinoic acid
(7e,9e,11e,13Z)-Retinoic acid
13 Cis-Retinoic Acid
13 cis retinoic acid
13-RA
13-cis RA
13-cis retinoic acid
13-cis-Retinoate
13-cis-Retinoic acid
13-cis-Vitamin A acid
13-cis-Vitamin a acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic acid
4-09-00-02388 (Beilstein Handbook Reference)
4759-48-2
97950-17-9
AC-15388
AC1NQZZ4
Absorica
Accutane
Accutane (TN)
Ambap302-79-4
Amnesteem
BML2-E07
BPBio1_000080
BRD-K76723084-001-05-9
BRN 1885770
BSPBio_000072
BSPBio_001331
BSPBio_003345
CCRIS 4286
CHEBI:6067
CHEMBL547
CID5282379
CIP-Isotretinoin
CPD000471891
Claravis
Clarus
D00348
D015474
EINECS 225-296-0
EU-0101081
Epuris
HMS1361C13
HMS1568D14
HMS1791C13
HMS1921D08
HMS1989C13
HMS2092N07
HSDB 3929
IDI1_033801
Isotane
Isotretinoin
Isotretinoin (USP)
 
Isotretinoin Retinoic acid
Isotretinoin Zinc Salt, 13 cis Isomer
Isotretinoin Zinc Salt, 13-cis-Isomer
Isotretinoin [USAN:BAN:INN]
Isotretinoin [USAN:INN:BAN]
Isotretinoina
Isotretinoine
Isotretinoine [INN-French]
Isotretinoino
Isotretinoino [INN-Spanish]
Isotretinoinum
Isotretinoinum [INN-Latin]
Isotrex
LMPR01090021
LS-143465
Lopac0_001081
MLS001074662
MolPort-003-666-394
Myorisan
NCGC00094358-01
NCGC00094358-02
NCGC00094358-03
NCGC00094358-04
NCGC00094358-05
NCGC00094358-06
NCGC00094358-07
NCGC00094358-08
NCGC00094358-09
NCGC00094358-13
Neovitamin A acid
Neovitamin a acid
Prestwick2_000256
Prestwick3_000256
Prestwick_642
R 3255
R3255_SIGMA
Retinoate
Retinoic acid
Ro 4 3780
Ro 4-3780
Ro 43780
Ro-4-3780
Ro-43780
Roaccutan
Roaccutane
Roacutan
SAM002548955
SMR000471891
SPECTRUM1502013
Sotret
Sotret (TN)
Spectrum5_001795
Spectrum5_001937
Teriosal
UNII-EH28UP18IF
Zenatane
cis-RA
cis-Retinoate
cis-Retinoic acid
isotretinoino
18
Oxandroloneapproved, investigationalPhase 21553-39-45878
Synonyms:
(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one
(4aS,4bS,6aS,7S,9aS,9bR,11aS)-7-hydroxy-4a,6a,7-trimethyltetradecahydroindeno[4,5-h]isochromen-2(1H)-one
17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one
17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one (9CI)
17beta-Hydroxy-17-methyl-2-oxa-5alpha-androstan-3-one
17beta-Hydroxy-17alpha-methyl-2-oxa-5alpha-androstan-3-one
2-Oxa-5alpha-androstan-3-one, 17beta-hydroxy-17-methyl- (8CI)
2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5-alpha,17-beta)- (9CI)
53-39-4
8075 C. B
8075 C. B.
8075 C.B
8075 C.B.
8075 CB
AC-14975
AC1L1LBY
Ambap53-39-4
Anavar
C07346
C19H30O3
CHEBI:7820
CHEMBL1200436
CID5878
D00462
DB00621
Dodecahydro-3-hydroxy-6-(hydroxy-methyl)-3,3a,6-trimethyl-1H-benz(e)indene-7-acetic acid delta-lactone
EINECS 200-172-9
 
HSDB 3373
LS-98540
Lonavar
MolPort-003-986-935
NSC 67068
OXANDROLONE
Ossandrolone
Ossandrolone [DCIT]
Oxandrin
Oxandrin (TN)
Oxandrin, Anavar, Oxandrolone
Oxandrolon
Oxandrolona
Oxandrolona [INN-Spanish]
Oxandrolone
Oxandrolone (JAN/USP/INN)
Oxandrolone [USAN:INN:BAN:JAN]
Oxandrolonum
Oxandrolonum [INN-Latin]
Protivar
Provitar
S1753_Selleck
SC 11585
SC-11585
TL8003512
UNII-7H6TM3CT4L
Vasorome
ZINC03813047
19
Tretinoinapproved, investigational, nutraceuticalPhase 2210302-79-45538, 444795
Synonyms:
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
.beta.-Retinoic acid
13497-05-7 (hydrochloride salt)
15-Apo-beta-caroten-15-oic acid
187175-63-9
1n4h
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)
302-79-4
5300-03-8
56573-65-0
7005-78-9
9(Z)-Retinoic acid
9-cis-RA
A-Acido (Argentina)
A-Vitaminsyre
A-Vitaminsyre [Denmark]
AC-6824
AC1L9GWO
AC1Q1J2J
AGN 100335
AGN 192013
AKOS000280845
ALRT 1057
AT-RA
ATRA
Aberel
Aberela
Aberela [Norway]
Accutane Roche
Acid A Vit (Belgium, Netherlands)
Acid, Retinoic
Acid, Vitamin A
Acid, all-trans-Retinoic
Acid, beta-all-trans-Retinoic
Acid, trans-Retinoic
Acide retinoique (French)
Acide retinoique (French) (DSL)
Acide retinoique (french) (dsl)
Acnavit
Acnavit [Denmark]
Airol
Aknefug
Aknoten
Alitretinoin
All Trans Retinoic Acid
All Trans-Retinoic Acid
All-(E)-Retinoate
All-(E)-Retinoic acid
All-trans Retinoic Acid
All-trans-Retinoate
All-trans-Retinoic acid
All-trans-Tretinoin
All-trans-Vitamin A acid
All-trans-Vitamin A1 acid
Alltrans-retinoic acid
Amnesteem
Atra-IV
Atragen
Atralin
Avita
Avita (TN)
Avita Gel
Avitoin
Avitoin [Norway]
BAL4079
BIDD:GT0483
BIDD:PXR0081
BML2-E05
BPBio1_000082
BRN 2057223
BSPBio_000074
BSPBio_001500
Betarretin
C00777
CCRIS 3294
CCRIS 7098
CHEBI:15367
CHEMBL38
CID444795
CPD000058245
Claravis
Cordes VAS [Germany]
Cordes vas
D00094
D014212
DB00523
DB00755
DB00982
Dermairol
EINECS 206-129-0
EU-0101061
Effederm
Effederm [France]
Epi-aberel
Eudyna
HMS1361K22
HMS1568D16
HMS1791K22
HMS1921D14
HMS1989K22
HMS2089D20
HMS2092N11
HMS502N05
HSDB 2169
HSDB 7186
I04-0008
I14-2351
IDI1_000903
IDI1_033970
Isotretinoin Retinoic acid
L000833
LGD 100057
LMPR01090019
LS-1154
Lopac0_001061
Lsotretinoin
MLS000028588
MLS001076515
MLS002207234
MLS002222211
MolPort-000-883-857
NCGC00017280-06
NCGC00017280-17
NCGC00021808-04
 
NCGC00021808-05
NCGC00021808-06
NCGC00021808-07
NCGC00021808-09
NCGC00021808-14
NCGC00021808-15
NSC 122758
NSC-122758
NSC122758
Nexret
Obagi
PDT-002-002
Panretin Gel
Panretyn
Potassium Salt, Tretinoin
Prestwick2_000257
Prestwick3_000257
Prestwick_424
R 2625
R0064
R2625_SIGMA
REA
RETINOIC ACID, ALL TRANS
RETINOIC acid
Refissa
Renova
Renova (TN)
Retacnyl
Retin A
Retin A (TN)
Retin-A
Retin-A Micro
Retin-a
Retin-a Micro
Retinoate
Retinoic acid
Retinoic acid, all-trans- (8CI)
Retinova
Retionic Acid
Retionic acid
Retisol-A
Retisol-a
Ro 1-5488
S1653_Selleck
SAM002264647
SMR000058245
SPECTRUM1502016
SR-01000000239
SR-01000000239-14
ST057075
Salt, Tretinoin Potassium
Salt, Tretinoin Sodium
Salt, Tretinoin Zinc
Sodium Salt, Tretinoin
Solage
Sotret
Spectrum5_001746
Spectrum5_001933
Stieva-A
Stieva-a
Stieva-a Forte
TRETINON
Tretin M
Tretin m
Tretin-x
Tretin.x
Tretinoin
Tretinoin (JAN/USP/INN)
Tretinoin (TN)
Tretinoin 0.1% cream or placebo
Tretinoin Cream
Tretinoin Gel Microsphere
Tretinoin Potassium Salt
Tretinoin Sodium Salt
Tretinoin Zinc Salt
Tretinoin [USAN:INN:BAN]
Tretinoin/All-Trans Retinoic Acid
Tretinoina
Tretinoina [INN-Spanish]
Tretinoine
Tretinoine (French)
Tretinoine (french) (einecs)
Tretinoine [INN-French]
Tretinoino
Tretinoino [INN-Spanish]
Tretinoinum
Tretinoinum [INN-Latin]
Tretinx
Tri-Luma
Trétinoïne
UNII-1UA8E65KDZ
UNII-5688UTC01R
UPCMLD-DP097
Vesanoid
Vesanoid (TN)
Vesanoid, Airol, Renova, Atralin, Retin-A, Avita, Tretinoin
Vesnaroid
Vitamin A acid
Vitinoin
WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1
Zinc Salt, Tretinoin
[3H]Retinoic acid
all trans-Retinoic acid
all-(E)-Retinoic acid
all-(e)-Retinoic acid
all-trans-Retinoic acid
all-trans-Tretinoin
all-trans-Vitamin A acid
all-trans-Vitamin A1 acid
all-trans-Vitamin a acid
all-trans-Vitamin a1 acid
all-trans-b-Retinoic acid
all-trans-beta-Retinoic acid
b-Retinoic acid
beta all trans Retinoic Acid
beta-Ra
beta-Retinoate
beta-Retinoic Acid
beta-Retinoic acid
beta-all-trans-Retinoic acid
bmse000562
nchembio.154-comp2
trans Retinoic Acid
trans-Retinoate
trans-Retinoic acid
tretinoin
tretinoin liposome
tretinoine (French) (EINECS)
20
Calcitriolapproved, nutraceuticalPhase 216132222-06-3134070, 5280453
Synonyms:
(1R,3S)-5-{2-[(1R,3aS,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol
(1S,3R,5Z,7e)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol
(1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(1alpha,3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol
(5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1-alpha,3-beta,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,25-triol
(5Z,7e)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
1 alpha,25-Dihydroxyvitamin D3
1,25 (OH)2 D3
1,25 Dihydroxycholecalciferol
1,25(OH)2-20epi-D3
1,25(OH)2D3 & CD4
1,25(OH2)D3
1,25-(OH)2-D3
1,25-(OH)2D3
1,25-DHCC
1,25-DIHYDROXYCHOLECALCIFEROL
1,25-Dihydroxycholecalciferol
1,25-Dihydroxycholecaliferol
1,25-Dihydroxyvitamin D
1,25-Dihydroxyvitamin D3
1,25-dihydroxy vitamin D3
1,25-dihydroxy-20-epi-Vitamin D3
1,25-dihydroxycholecalciferol
1,25D3
1-alpha,-1,25-Dihydroxyvitamin D3
1-alpha,25-Dihydroxycholecalciferol
1-alpha,25-Dihydroxyvitamin D3
1-alpha-25-Dihydroxyvitamin D3
1-alpha-25-dihydroxyvitamin D3
1.Alpha.,25-Dihydroxy-26,27-hexadeuterovitamin D3
17936_FLUKA
17936_SIGMA
1a,25-(OH)2D3
1a,25-Dihydroxycholecalciferol
1a,25-Dihydroxyvitamin D3
1alpha,25(OH)2-D3
1alpha,25(OH)2D3
1alpha,25-Dihydroxycholecalciferol
1alpha,25-Dihydroxyvitamin D
1alpha,25-Dihydroxyvitamin D3
1db1
1α,25(OH)2D3
1α,25-dihydroxycholecalciferol
1α,25-dihydroxyvitamin D3
20-epi-1alpha,25-dihydroxycholecaliferol
25-Dihydroxycholecalciferol
32222-06-3
5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha,3beta,25-triol
9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)- & CD4
9,10-seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha, 3beta, 25-triol
AC-1859
AC1NQX1S
 
Ambap32222-06-3
Asentar
BCBcMAP01_000160
BML2-E03
BSPBio_001287
C01673
CCRIS 5522
CD-2027
CHEBI:17823
CHEMBL846
CID5280453
CPD000466393
Calcijex
Calcijex, Silkis, Rocaltrol, Topitriol, Cholecalciferol,Calcitriol
Calcitriol
Calcitriol (JAN/USAN/INN)
Calcitriol [USAN:INN:BAN:JAN]
Calcitriolum
Calcitriolum [INN-Latin]
D00129
D1530_SIGMA
DN 101
DN-101
Decostriol
Dihydroxyvitamin D3
EINECS 250-963-8
HMS1361A09
HMS1791A09
HMS1989A09
HMS2051F06
HMS2089N03
HSDB 3482
IDI1_033757
LMST03020258
LS-53093
MC-1288
MC1288
MLS000759536
MLS001424122
MolPort-002-045-698
NCGC00161327-01
NCGC00161327-04
Ro 21-5535
Ro 215535
Ro-21-5535
Rocaltrol
Rocaltrol (TN)
S1466_Selleck
SAM001246772
SMR000466393
Silkis
Soltriol
Spectrum5_002061
Topitriol
Toptriol
U 49562
Vectical
ZINC03924790
calcitriol
vit D
21Vasoconstrictor AgentsPhase 21303
22vitamin dPhase 21524
23VitaminsPhase 23857
24MicronutrientsPhase 23901
25Trace ElementsPhase 23900
26Calcium, DietaryPhase 24678
27Keratolytic AgentsPhase 2273
28Dermatologic AgentsPhase 24555
29DihydroxycholecalciferolsPhase 227
30Bone Density Conservation AgentsPhase 22600
31Insulin, Globin Zinc4278
32insulin4278
33Hemostatics1082

Interventional clinical trials:

(show all 26)
idNameStatusNCT IDPhase
1Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone TreatmentRecruitingNCT02408445Phase 4
2Androgen for Leydig Cell ProliferationCompletedNCT01206270Phase 2, Phase 3
3Androgen Effect on Klinefelter Syndrome Motor OutcomeActive, not recruitingNCT00348946Phase 2
4RA-2 13-cis Retinoic Acid (Isotretinoin)Active, not recruitingNCT02061384Phase 2
5Elucidating Kisspeptin Physiology by Blocking Kisspeptin SignalingRecruitingNCT01438073Phase 1
6Neuropsychologic, Neuroradiologic, Endocrinologic, and Genetic Aspects of Klinefelter SyndromeCompletedNCT00999310
7Adaptation Among Adolescents and Adults With Klinefelter SyndromeCompletedNCT00896272
8Epigenetics and Metabolic Disorders in Men With the Klinefelter SyndromeCompletedNCT01703676
9Life Quality and Health in Patients With Klinefelter SyndromeCompletedNCT01690013
10Klinefelter Fertility PreservationCompletedNCT01817296
11Body Composition, Bone Mineral Density, Insulin Sensitivity and Echocardiographic Measurements in Klinefelter SyndromeCompletedNCT00523835
12X-chromosome Inactivation, Epigenetics and the TranscriptomeCompletedNCT01678261
13Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell InjectionCompletedNCT02414295
14Development and Decline of Brain and Cognition Through the Life SpanCompletedNCT00880451
15Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter SyndromeRecruitingNCT01585831
16Fertility Preservation in Cases of Klinefelter Syndrome.RecruitingNCT01918280
17Fertility Assessment in Patients With Klinefelter SyndromeRecruitingNCT02461303
18Thrombosis and Neurocognition in Klinefelter SyndromeRecruitingNCT02526628
19Subcapsular Orchiectomy in Men With Klinefelter SyndromeRecruitingNCT01750632
20The Clinical Study of Sex Chromosome VariantsRecruitingNCT01661010
21Non-Invasive Determination of Fetal Chromosome AbnormalitiesRecruitingNCT00891852
22Whole Blood Specimen Collection From Pregnant SubjectsRecruitingNCT02430584
23Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNARecruitingNCT02109770
24Cardiometabolic Profiles of Boys With Klinefelter SyndromeNot yet recruitingNCT02723305
25Testicular Tissue Cryopreservation for Fertility Preservation in Male Patients Facing Infertility-causing Diseases or Treatment RegimensNot yet recruitingNCT02687880
26Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter SyndromeWithdrawnNCT00347464

Search NIH Clinical Center for Klinefelter's Syndrome


Cochrane evidence based reviews: klinefelter syndrome

Genetic Tests for Klinefelter's Syndrome

About this section

Genetic tests related to Klinefelter's Syndrome:

id Genetic test Affiliating Genes
1 Hypogonadotropic Hypogonadism22

Anatomical Context for Klinefelter's Syndrome

About this section

MalaCards organs/tissues related to Klinefelter's Syndrome:

33
Breast, Testes, Bone, Endothelial, Brain, Liver, Lung

Animal Models for Klinefelter's Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Klinefelter's Syndrome:

38 (show all 11)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053759.4AR, CYP19A1, KISS1, KISS1R, MECP2
2MP:00028738.4AR, CYP19A1, FGFR1, GNRH1, GNRHR, KISS1R
3MP:00053708.4AR, CYP19A1, GNRH1, KISS1, KISS1R, MECP2
4MP:00053818.3AR, CYP19A1, FGFR1, GNRH1, GNRHR, KISS1
5MP:00053678.3AR, CYP19A1, FGFR1, GNRH1, GNRHR, KISS1
6MP:00053908.1AR, CYP19A1, FGFR1, GNRH1, INSL3, KISS1R
7MP:00107717.6AR, CYP19A1, FGFR1, GNRH1, GNRHR, KISS1
8MP:00053767.0AMH, AR, CYP19A1, FGFR1, GNRH1, GNRHR
9MP:00053796.8AMH, AR, CYP19A1, FGFR1, GNRH1, GNRHR
10MP:00053896.8AMH, AR, CYP19A1, FGFR1, GNRH1, GNRHR

Publications for Klinefelter's Syndrome

About this section

Articles related to Klinefelter's Syndrome:

(show top 50)    (show all 513)
idTitleAuthorsYear
1
A Case of Copper Deficiency-Induced Pancytopenia With Maintenance Hemodialysis Outpatient Treated With Polaprezinc. (26948531)
2016
2
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function. (25770198)
2015
3
Child Neurology: Molybdenum cofactor deficiency. (26644055)
2015
4
PPI network analysis of mRNA expression profile of ezrin knockdown in esophageal squamous cell carcinoma. (25126570)
2014
5
Plasma angiopoietin-1 is lower after ischemic stroke and associated with major disability but not stroke incidence. (24569814)
2014
6
Evaluation of femtosecond laser-assisted and manual clear corneal incisions and their effect on surgically induced astigmatism and higher-order aberrations. (25325892)
2014
7
Journal club: role of endoscopic third ventriculostomy and ventriculoperitoneal shunt in idiopathic normal pressure hydrocephalus: preliminary results of a randomized clinical trial. (24141398)
2013
8
A longitudinal study on I+-synuclein in blood plasma as a biomarker for Parkinson's disease. (23985836)
2013
9
The immunosuppressive agent mizoribine monophosphate is an inhibitor of the human RNA capping enzyme. (23349942)
2013
10
Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes. (23554290)
2013
11
Whole mitochondrial DNA variations in hippocampal surgical specimens and blood samples with high-throughput sequencing: a case of mesial temporal lobe epilepsy with hippocampal sclerosis. (23872536)
2013
12
The interaction of scientific evidence and politics in debates about preventing malaria in 1925. (24097965)
2013
13
Optical treatment strategies to slow myopia progression: effects of the visual extent of the optical treatment zone. (23290590)
2013
14
Acute activation of I^2-adrenergic receptor regulates focal adhesions through I^Arrestin2- and p115RhoGEF protein-mediated activation of RhoA. (22500016)
2012
15
Is there a morning-to-evening difference in the acute IL-6 and cortisol responses to resistance exercise? (21632260)
2011
16
Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120. (21121641)
2011
17
Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences. (21849175)
2011
18
Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension. (20075930)
2010
19
The place of L-dopa/carbidopa in persistent vegetative state. (21060281)
2010
20
Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp. (19351723)
2009
21
Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice. (19136718)
2009
22
Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. (19592276)
2009
23
Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors. (19724685)
2009
24
Pleomorphic xanthoastrocytoma presenting with life-threatening hemorrhage in a child. (19278318)
2009
25
Effect of renal replacement therapy on retinol-binding protein 4 isoforms. (19046959)
2009
26
An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis. (18408167)
2008
27
The bZip transcription factor Cgap1p is involved in multidrug resistance and required for activation of multidrug transporter gene CgFLR1 in Candida glabrata. (17046176)
2007
28
Diagnosis and management of accommodative esotropia. (16907672)
2006
29
BAFF: A regulatory cytokine of B lymphocytes involved in autoimmunity and lymphoid cancer]. (17171221)
2006
30
Management of intrahepatic recurrence after curative treatment of colorectal liver metastases. (16705643)
2006
31
Accessory deep peroneal nerve. (15069275)
2004
32
Overexpression of the Wilms' tumor gene WT1 in esophageal cancer. (15510596)
2004
33
Role of semaphorins in the adult nervous system. (14687984)
2003
34
Ecthyma gangrenosum caused by disseminated Exserohilum in a child with leukemia: a case report and review of the literature. (14651568)
2003
35
Unilateral progressive multiple sclerosing hemangioma in a young female successfully treated by pneumonectomy: report of a case. (12222919)
2002
36
Effect of hypoxia on human seminoma cells. (11956589)
2002
37
Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. (12401499)
2002
38
The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. (11001930)
2000
39
Establishment of cisplatin-induced multidrug resistant human epithelial ovarian cancer cell line 3AO/cDDP and its expressions of multidrug resistance proteins]. (11372415)
2000
40
Detection of beta-A4 amyloid and its precursor protein in the muscle of a patient with juvenile neuronal ceroid lipofuscinosis (Spielmeyer-Vogt-SjAPgren). (10412803)
1999
41
Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients. (10553163)
1999
42
Clinical significance of serum thrombomodulin levels in patients with systemic rheumatic diseases. (9093774)
1997
43
The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. (8989733)
1996
44
Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination. (7655135)
1995
45
Inhibition of cdc2 activation by INH/PP2A. (8049524)
1994
46
Venepuncture for calcium assays: should we still avoid the tourniquet? (2217012)
1990
47
Alpha-L-fucosidase isoenzyme pattern in hairy cell leukaemia. (2332987)
1990
48
Systemic and regional hemodynamic characteristics of bilateral cellophane perinephritis hypertension in conscious rabbits. (6883748)
1983
49
Warfarin-resistance genotype determination in the Norway rat, Rattus norvegicus. (553191)
1979
50
Use of acoustic impedance measurement in screening for middle ear disease in children. Task Force of the Symposium on Impedance Screening for Children. (714589)
1978

Variations for Klinefelter's Syndrome

About this section

Expression for genes affiliated with Klinefelter's Syndrome

About this section
Search GEO for disease gene expression data for Klinefelter's Syndrome.

Pathways for genes affiliated with Klinefelter's Syndrome

About this section

Pathways related to Klinefelter's Syndrome according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.7AR, AZF1, MECP2
29.6AR, GNRH1
39.5GNRH1, GNRHR

GO Terms for genes affiliated with Klinefelter's Syndrome

About this section

Biological processes related to Klinefelter's Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1sex differentiationGO:00075489.5AMH, AR
2regulation of gene expressionGO:00104688.9AR, FGFR1, GNRH1, MECP2

Sources for Klinefelter's Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet